Charles Schwab Investment Management Inc Avita Medical, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Avita Medical, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 85,817 shares of RCEL stock, worth $348,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,817
Previous 64,215
33.64%
Holding current value
$348,417
Previous $522,000
13.22%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RCEL
# of Institutions
86Shares Held
7.6MCall Options Held
46.5KPut Options Held
18.5K-
Black Rock Inc. New York, NY1.78MShares$7.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$5.89 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA618KShares$2.51 Million0.0% of portfolio
-
State Street Corp Boston, MA529KShares$2.15 Million0.0% of portfolio
-
Ubs Group Ag410KShares$1.66 Million0.0% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $102M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...